• Profile
Close

Tumor-infiltrating lymphocyte as a prognostic biomarker in stage IV colorectal cancer should take into account the metastatic status and operation modality

Cancer Management and Research Jun 11, 2018

Xie QK, et al. - Researchers investigated the prognostic significance of tumor-infiltrating lymphocytes (TILs) in metastatic colorectal cancer (mCRC) and the association of this prognostic benefit with the metastatic status and operation modality. Cox proportional hazards regression was used to assess the prognostic value of TILs, and patients newly diagnosed with stage IV CRC and surgically treated at the Sun Yat-Sen University Cancer Center between 2009 and 2014 were involved. They found better survival was strongly predicted by high TIL, independent of other patients’ clinicopathological characteristics, as corroborated in multivariable analysis. Overall, TILs level can serve as a prognostic biomarker in patients with mCRC but the operation modality and the metastatic status of patients should also be considered.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay